Intellia Therapeutics Inc buy Cantor Fitzgerald
Start price
18.06.24
/
50%
€22.97
Target price
18.06.25
€60.53
Performance (%)
-28.65%
Price
04.10.24
€16.39
Summary
This prediction is currently active. The price of Intellia Therapeutics Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -28.65%. This prediction currently runs until 18.06.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | -12.912% | -12.912% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€23.43
24.06.24
24.06.24
€60.53
24.06.25
24.06.25
-30.05%
04.10.24
04.10.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€21.64
04.06.24
04.06.24
€59.71
04.06.25
04.06.25
-24.26%
04.10.24
04.10.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€34.13
13.09.23
13.09.23
€60.55
13.09.24
13.09.24
-41.20%
14.09.24
14.09.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.09
29.08.23
29.08.23
€59.70
29.08.24
29.08.24
-42.43%
30.08.24
30.08.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€37.03
10.08.23
10.08.23
€58.92
10.08.24
10.08.24
-46.44%
11.08.24
11.08.24